lunes, 5 de mayo de 2014

Media Availability: Tdap Vaccination During Pregnancy Likely to Protect Newborns from Pertussis

Media Availability: Tdap Vaccination During Pregnancy Likely to Protect Newborns from Pertussis



Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases
NIAID News Twitter   NIAID Facebook   NIAID News Twitter   LinkedIn Icon
Visit us on the Web
Tdap Vaccination During Pregnancy Likely to Protect Newborns from Pertussis

Vaccinating pregnant women with tetanus, diphtheria and acellular pertussis (Tdap) vaccine is safe, induces an immune response in women and is likely to protect newborns against pertussis, according to the results of a recent clinical trialconducted by NIAID-supported researchers at Baylor College of Medicine, Houston.




Pertussis—also known as whooping cough—is a bacterial disease that can cause serious illness, especially in babies who are too young to receive a vaccine to prevent it. Read more about the trial at http://www.niaid.nih.gov/news/newsreleases/2014/Pages/tdap.aspx#.

No hay comentarios:

Publicar un comentario